Form 4 for ISRG Intuitive Surgical
Accepted 2024-04-24 00:00:00 ET · period of report 2024-04-23 · accession 0001035267-24-000139 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-24 | 2024-04-23 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $180.27 | +5,318 | 3,116 | New | +$958.7K |
| DM | 2024-04-24 | 2024-04-23 | ISRG | Curet Myriam | EVP, Chief Medical Off | S - Sale+OE | $370.66 | -5,318 | 298 | -95% | -$1.97M |
| DM | 2024-04-24 | 2024-04-23 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | -5,318 | 5,075 | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-23 | M | A | 2,500 | $182.83 | 2,798 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-23 | S | D | 2,818 | $370.66 | 298 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.86 to $371.98 as follows: 700 shares sold at $368.86 to $369.85; 3,321 shares sold at $369.99 to $370.94; and 1,297 shares sold at $371.03 to $371.98. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-04-23 | M | A | 2,818 | $177.99 | 3,116 | D | — | — | |
| 4 | Common | Common Stock | 2024-04-23 | S | D | 2,500 | $370.66 | 298 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.86 to $371.98 as follows: 700 shares sold at $368.86 to $369.85; 3,321 shares sold at $369.99 to $370.94; and 1,297 shares sold at $371.03 to $371.98. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-04-23 | M | D | 2,500 | $0.00 | 5,000 | D | $182.83 · — to 2029-02-15 | 2,500 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-04-23 | M | D | 2,818 | $0.00 | 5,075 | D | $177.99 · — to 2030-02-28 | 2,818 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |